1. Cleare MJ (1984) Further objectives in the development of platinum drugs. In: Harrap KR, Davis W, Calvert AH (eds) Cancer chemotherapy and selective drug development. Nijhoff, Boston pp 357?362
2. Ehresmann K (1985) Synthese und Eigenschaften cytostatisch wirksamer 2-Chloroethylnitrosoharnstoffe. Inaug Diss, University Heidelberg
3. Ehresmann K, Zelezny O, Eisenbrand G (1984) Syntheses of potentially antineoplastic amides and esters of N-[N?(2-chloroethyl)-N?-nitrosocarbamoyl] amino acids, II. Arch Pharm 317:481?487
4. Eisenbrand G, Habs M, Zeller WJ, Fiebig H, Berger M, Zelezny O, Schmähl D (1981) New Nitrosoureas ? therapeutic and long-term toxic effects of selected compounds in comparison to established drugs. In: Serrou B, Schein PS, Imbach JL (eds) Nitrosoureas in cancer treatment. Elsevier, Amsterdam, pp 175?191
5. Eisenbrand G, Tang W, Zelezny O (1983) N-(N?-(2-Chloräthyl)-N?-nitroso-carbamoyl)-oligopeptidester und-amide und Verfahren zu ihrer Herstellung. EP 0 074 103 A1 (Int. Cl. C 07 C103/52)